Department of Integrated Omics for Biomedical Sciences, Yonsei University, Seoul 03722, Korea.
Institute for Bio-Medical Convergence, College of Medicine, Catholic Kwandong University, Gangneung-si 25601, Korea.
Int J Mol Sci. 2021 Jul 26;22(15):7946. doi: 10.3390/ijms22157946.
The acute demise of stem cells following transplantation significantly compromises the efficacy of stem cell-based cell therapeutics for infarcted hearts. As the stem cells transplanted into the damaged heart are readily exposed to the hostile environment, it can be assumed that the acute death of the transplanted stem cells is also inflicted by the same environmental cues that caused massive death of the host cardiac cells. Pyroptosis, a highly inflammatory form of programmed cell death, has been added to the list of important cell death mechanisms in the damaged heart. However, unlike the well-established cell death mechanisms such as necrosis or apoptosis, the exact role and significance of pyroptosis in the acute death of transplanted stem cells have not been explored in depth. In the present study, we found that M1 macrophages mediate the pyroptosis in the ischemia/reperfusion (I/R) injured hearts and identified miRNA-762 as an important regulator of interleukin 1β production and subsequent pyroptosis. Delivery of exogenous miRNA-762 prior to transplantation significantly increased the post-transplant survival of stem cells and also significantly ameliorated cardiac fibrosis and heart functions following I/R injury. Our data strongly suggest that suppressing pyroptosis can be an effective adjuvant strategy to enhance the efficacy of stem cell-based therapeutics for diseased hearts.
移植后干细胞的急性死亡显著降低了基于干细胞的细胞疗法治疗梗死心脏的疗效。由于移植到受损心脏中的干细胞很容易暴露于恶劣的环境中,可以假设移植的干细胞的急性死亡也是由导致宿主心肌细胞大量死亡的相同环境线索引起的。细胞焦亡,一种高度炎症形式的程序性细胞死亡,已被添加到受损心脏中重要的细胞死亡机制列表中。然而,与坏死或细胞凋亡等成熟的细胞死亡机制不同,细胞焦亡在移植干细胞的急性死亡中的确切作用和意义尚未被深入探索。在本研究中,我们发现 M1 巨噬细胞介导缺血/再灌注 (I/R) 损伤心脏中的细胞焦亡,并确定 miRNA-762 是白细胞介素 1β产生和随后细胞焦亡的重要调节因子。移植前递送外源性 miRNA-762 可显著增加干细胞的移植后存活率,并显著改善 I/R 损伤后的心脏纤维化和心功能。我们的数据强烈表明,抑制细胞焦亡可能是增强基于干细胞的治疗方法治疗患病心脏疗效的有效辅助策略。